Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sotatercept in MPN-Associated Myelofibrosis and Anemia
NCT01712308Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Feb 2013
- Primary completion
- May 2022
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of sotatercept in myelofibrosis (MF), sponsored by University of Texas MD Anderson Cancer Center. Started Feb 2013; status: completed.
02
Drugs
sotatercept
03
Conditions
myelofibrosis (MF)
Beyond the preview
Go deeper on NCT01712308.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01712308.